Both the number of deals and the amount of money being invested in life science ...
The EU in 2022 ruled that the purchase violated antitrust rules, and Thursday’s ...
Centering mothers and families in the care of preterm infants and keeping mother...
The second installment of STAT's rural health series explores why rural residenc...
Peter Marks wants drug developers to ask more stupid questions. It’s part of the...
It’s no secret that biotech industry funding has fallen from its Covid highs. Bu...
As AdvaMed concludes, here are the key takeaways from the world’s largest medica...
A company that Pfizer blamed for problems with a clinical trial testing a Lyme v...
Bruce Broussard will leave Humana next year. Jim Rechtin, CEO of the bankrupt En...
A handful of states are moving aggressively to slash drug costs for their reside...
This week, European regulators are considering an appeal from Amylyx Pharmaceuti...
In a major test for biotechnology company eGenesis, gene-edited pig kidneys kept...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Novo Nordisk plans to stop a trial of Ozempic to treat kidney failure after an i...
The Wellcome Trust — the world’s second largest private funder of biomedical res...
Chronic kidney disease was the strongest risk factor for sudden cardiac arrest a...
